Pyxis Oncology Analyst Ratings
Pyxis Oncology Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 509.76% | EF Hutton | → $15 | Initiates Coverage On | → Buy |
| 03/23/2023 | 469.11% | Credit Suisse | → $14 | Reiterates | → Outperform |
| 11/02/2021 | 550.41% | B of A Securities | → $16 | Initiates Coverage On | → Neutral |
| 11/02/2021 | 916.26% | Jefferies | → $25 | Initiates Coverage On | → Buy |
| 11/02/2021 | 672.36% | Credit Suisse | → $19 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/31/2023 | 509.76% | EF Hutton | → 15 美元 | 启动覆盖开启 | → 购买 |
| 03/23/2023 | 469.11% | 瑞士信贷 | → 14 美元 | 重申 | → 跑赢大盘 |
| 11/02/2021 | 550.41% | B of A 证券 | → 16 美元 | 启动覆盖开启 | → 中立 |
| 11/02/2021 | 916.26% | 杰富瑞 | → 25 美元 | 启动覆盖开启 | → 购买 |
| 11/02/2021 | 672.36% | 瑞士信贷 | → 19 美元 | 启动覆盖开启 | → 跑赢大盘 |
What is the target price for Pyxis Oncology (PYXS)?
Pyxis Oncology (PYXS) 的目标价格是多少？
The latest price target for Pyxis Oncology (NASDAQ: PYXS) was reported by EF Hutton on July 31, 2023. The analyst firm set a price target for $15.00 expecting PYXS to rise to within 12 months (a possible 509.76% upside). 2 analyst firms have reported ratings in the last year.
EF Hutton于2023年7月31日公布了Pyxis Oncology（纳斯达克股票代码：PYXS）的最新目标股价。这家分析公司将目标股价定为15.00美元，预计PYXS将在12个月内升至15.00美元（可能上涨509.76％）。去年有2家分析公司公布了评级。
What is the most recent analyst rating for Pyxis Oncology (PYXS)?
分析师对 Pyxis Oncology (PYXS) 的最新评级是多少？
The latest analyst rating for Pyxis Oncology (NASDAQ: PYXS) was provided by EF Hutton, and Pyxis Oncology initiated their buy rating.
Pyxis Oncology（纳斯达克股票代码：PYXS）的最新分析师评级由EF Hutton提供，Pyxis Oncology启动了买入评级。
When is the next analyst rating going to be posted or updated for Pyxis Oncology (PYXS)?
Pyxis Oncology（PYXS）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pyxis Oncology, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pyxis Oncology was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
分析师在进行了广泛的研究，包括浏览公开财务报表、与Pyxis Oncology的高管和客户交谈以及听取财报电话会议后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Pyxis Oncology 的最后评级是在2023年7月31日提交的，因此您应该预计下一个评级将在2024年7月31日左右公布。
Is the Analyst Rating Pyxis Oncology (PYXS) correct?
分析师对 Pyxis Oncology (PYXS) 的评级是否正确？
While ratings are subjective and will change, the latest Pyxis Oncology (PYXS) rating was a initiated with a price target of $0.00 to $15.00. The current price Pyxis Oncology (PYXS) is trading at is $2.46, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的Pyxis Oncology（PYXS）评级是最初的，目标股价为0.00美元至15.00美元。Pyxis Oncology（PYXS）目前的交易价格为2.46美元，在分析师的预测区间内。